SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language
International | eng
Country Language

MitraClip™

Transcatheter Edge-to-Edge Repair (TEER)

MitraClip

Life-Changing TEER Therapy for Select Patients with Mitral Regurgitation

MitraClip™ is the world’s first mitral transcatheter edge-to-edge repair (TEER) therapy -- also referred to as TMVr (transcatheter mitral valve repair) -- that delivers a minimally invasive treatment option for select patients with primary or secondary mitral regurgitation (MR) who would otherwise go untreated.1,2 With more than 18 years of clinical experience and over 150,000 patients treated worldwide, MitraClip™ is a well-established procedure with the highest-reported MR reduction, proven safety and survival, and durable clinical outcomes.3,9

Learn about the clinical performance of the MitraClip™ TEER System.

Tailored. Optimized. Proven.

At Abbott, we continue to innovate with the fourth-generation MitraClip™ device. MitraClip™ G4 features several enhancements that offer physicians more treatment options that can be tailored to a patients' unique mitral valve anatomy.
 

Expanded Range of Clip Sizes

A total of 4 clip sizes—now including clips with wider grasping area—gives physicians the ability to choose a clip size based on each patient’s mitral valve anatomy.1,4-5

Controlled Gripper Actuation (CGA)

With more options to confirm and optimize leaflet grasping, CGA allows physicians to grasp leaflets simultaneously or independently.1,4

Predictable Procedure Experience4-5

Precision and control from a delivery system specifically designed for the mitral valve facilitates Left Atrial Pressure (LAP) monitoring.4

ESC/EACTS and ESC/HF Guideline Favor Intervention

 

MitraClip™ is the only TEER therapy recommended by the 2021 ESC/EACTS and ESC/HF Guidelines. Determining the severity of MR is an important factor in the management of the condition. The guidelines support aggressive monitoring and early action, with the goal of preventing complications due to left ventricular volume overload.7,8

ACC/AHA Treatment Guidelines

Learn more about MitraClip™ TEER by visiting the Abbott Structural Heart website

View MitraClip™ TEER Clinical Data
Abbott Structural Heart Website

Ordering Information

Europe, Middle East, and Africa

MitraClip™ G4 System

Product CodeDescriptionPiece Count
MC0702-NTMitraClip G4 NT bundle [Contents: one (1) CDS0702-NT, one (1) SGC0702]2
MC0702-XTMitraClip G4 XT bundle [Contents: one (1) CDS0702-XT, one (1) SGC0702]2
MC0702-NTWMitraClip G4 NTW bundle [Contents: one (1) CDS0702-NTW, one (1) SGC0702]2
MC0702-XTWMitraClip G4 XTW bundle [Contents: one (1) CDS0702-XTW, one (1) SGC0702]2
CDS0702-NTMitraClip G4 NT Clip Delivery System1
CDS0702-XTMitraClip G4 XT Clip Delivery System1
CDS0702-NTWMitraClip G4 NTW Clip Delivery System1
CDS0702-XTWMitraClip G4 XTW Clip Delivery System1
SGC0702MitraClip G4 Steerable Guide Catheter1


Required Accessories

Product CodeDescriptionPiece Count
SZR01STStabilizer1
LFT01STLift1
PLT01STSupport Plate1


Other Countries

MitraClip™ G4 System

Product CodeDescriptionPiece Count
CDS0705-NTMitraClip G4 NT Clip Delivery System1
CDS0705-NTWMitraClip G4 NTW Clip Delivery System1
CDS0705-XTMitraClip G4 XT Clip Delivery System1
CDS0705-XTWMitraClip G4 XTW Clip Delivery System1
SGC0705MitraClip G4 Steerable Guide Catheter1


Required Accessories

Product CodeDescriptionPiece Count
SZR01STStabilizer1
LFT01STLift1
PLT01STSupport Plate1

References

  1. MitraClip G4 Instructions for Use.
  2. Lim DS, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after the transcatheter mitral valve repair. J Am Coll Cardiol. 2014;64(2):182-192.
  3. Data on file at Abbott.
  4. Tests performed by and data on file at Abbott.
  5. Rottbauer W. D. Contemporary Clinical Outcomes with MitraClip™ (NTR/XTR) System: Core-lab Echo Results from +1000 Patient the Global EXPAND Study. Data presented at PCR 2020.
  6. Maisano F. Clip Selection Strategy and Outcomes with MitraClip™ (NTR/XTR): Evidence-Based Recommendations from the Global EXPAND Study. Data presented at PCR 2020.
  7. Vahanian A, Beyersdorf F, Praz F, et al., ESC/EACTS Scientific Document Group, 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal, Volume 43, Issue 7, 14 February 2022, Pages 561–632
  8. McDonagh TA, Metra M, Adamo M, et al., ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3599–3726

MAT-2100248 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2023 Abbott. All Rights Reserved.

MAT-2001111 v5.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

MAT-2305078 v1.0